SANTA CLARA, Calif.–(BUSINESS WIRE)– #HFrEF–Ancora Heart, Inc., a medical device company developing a transcatheter device-based therapy to address heart failure (HF), today announced that two-year results from an analysis of early clinical studies evaluating the AccuCinch® Transcatheter Left Ventricular Restoration System were published in Structural Heart. The findings demonstrate that reverse remodeling achieved with the AccuCinch System was sustained through two years, along with improvements in